Arcutis Biotherapeutics, Inc. (ARQT)
23.81
-0.16
(-0.67%)
USD |
NASDAQ |
Sep 01, 14:10
Arcutis Biotherapeutics Cash and Short Term Investments (Quarterly) : 238.86M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 238.86M |
| March 31, 2026 | 224.31M |
| December 31, 2025 | 221.29M |
| September 30, 2025 | 191.38M |
| June 30, 2025 | 191.13M |
| March 31, 2025 | 198.70M |
| December 31, 2024 | 228.57M |
| September 30, 2024 | 331.18M |
| June 30, 2024 | 363.05M |
| March 31, 2024 | 404.48M |
| December 31, 2023 | 272.79M |
| September 30, 2023 | 228.04M |
| June 30, 2023 | 269.60M |
| March 31, 2023 | 333.33M |
| December 31, 2022 | 410.82M |
| September 30, 2022 | 478.20M |
| Date | Value |
|---|---|
| June 30, 2022 | 283.40M |
| March 31, 2022 | 344.84M |
| December 31, 2021 | 388.60M |
| September 30, 2021 | 368.81M |
| June 30, 2021 | 410.91M |
| March 31, 2021 | 446.47M |
| December 31, 2020 | 285.98M |
| September 30, 2020 | 189.71M |
| June 30, 2020 | 223.98M |
| March 31, 2020 | 249.32M |
| December 31, 2019 | 101.26M |
| September 30, 2019 | 25.18M |
| June 30, 2019 | 35.86M |
| March 31, 2019 | |
| December 31, 2018 | 50.94M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Insmed, Inc. | 1.160B |
| Emergent BioSolutions, Inc. | 140.90M |
| Exelixis, Inc. | 839.38M |
| Vertex Pharmaceuticals, Inc. | 7.863B |